Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Curr Osteoporos Rep. 2020 Jun;18(3):189–198. doi: 10.1007/s11914-020-00572-9

Table 2.

Cell lineage of potential SSCs in regenerative conditions

Gene Constitutively active cre or inducible creER Tamoxifen injection Surgery Chase Cell lineage
Pthrp29 CreER P6 Chondrocyte ablation P21 Day 7 Osteoblasts
Cathepsin K31 Cre Complete fracture 6W Days 6, 9, and 15 Chondrocytes, osteoblasts and periosteal cells
aSMA49, 50 CreER Day0, –1 Complete fracture 3–5M Days 2, 6, 7, and 14 Chondrocytes and osteoblasts
Osterix52 CreER P5 Complete fracture 32W Day 8 Chondrocytes and osteoblasts
Lepr53 Cre Complete fracture 2M Days 14 and 56 Chondrocytes and osteoblasts
Cxcl1232 CreER Day – 7 Complete fracture 6–10W Days 2, 7, 14, and 56 Chondrocytes and osteoblasts
Bone marrow ablation Chondrocytes and osteoblasts
Drill-hole injury Osteoblasts